• Ilaria Ferlenghi, GlaxoSmithKline plc, Siena, Italy
  • Ray Owens, University of Oxford, UK
  • Matthias Frech, Merck-Serono, Darmstadt, Germany
  • Chris Tate, MRC Laboratory of Molecular Biology, Cambridge, UK
  • Sandra Jacob, Novartis, Basel, Switzerland
  • Roger Williams, MRC Laboratory of Molecular Biology, Cambridge, UK
  • Puja Pathuri, Astex Pharmaceuticals, Cambridge, UK
  • Stephen Cusack, EMBL Grenoble Outstation, France